Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet.


Journal

Expert review of clinical pharmacology
ISSN: 1751-2441
Titre abrégé: Expert Rev Clin Pharmacol
Pays: England
ID NLM: 101278296

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 30 9 2020
medline: 5 2 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

Technical and logical breakthroughs have provided new opportunities in medicine to use knowledge bases and large-scale clinical data (real-world) at point-of-care as part of a learning healthcare system to diminish the knowledge-practice gap. The article is based on presentations, discussions and recommendations from an international scientific workshop. Value, research needs and funding avenues of knowledge bases and access to real-world data as well as transparency and incorporation of patient perspectives are discussed. Evidence-based, publicly funded, well-structured and curated knowledge bases are of global importance. They ought to be considered as a public responsibility requiring transparency and handling of conflicts of interest. Information has to be made accessible for clinical decision support systems (CDSS) for healthcare staff and patients. Access to rich and real-world data is essential for a learning health care ecosystem and can be augmented by data on patient-reported outcomes and preferences. This field can progress by the establishment of an international policy group for developing a best practice guideline on the development, maintenance, governance, evaluation principles and financing of open-source knowledge bases and handling of real-world data.

Identifiants

pubmed: 32990065
doi: 10.1080/17512433.2020.1805314
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

925-934

Subventions

Organisme : Austrian Science Fund FWF
ID : P 29076
Pays : Austria

Auteurs

Mikael Hoffmann (M)

The NEPI Foundation - Swedish Network for Pharmacoepidemiology, Linköping University , Linköping, Sweden.

Robert Vander Stichele (R)

Clinical Pharmacology Research Unit, Heymans Institute of Pharmacology, Ghent University , Ghent, Belgium.

David W Bates (DW)

Center for Patient Safety Research and Practice, Division of General Internal Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts, USA.

Johanna Björklund (J)

Department of Computing Science, Umeå University , Umeå, Sweden.

Steve Alexander (S)

School of Life Sciences, University of Nottingham Medical School , Nottingham, UK.

Marine L Andersson (ML)

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden.

Ane Auraaen (A)

Organisation for Economic Cooperation and Development (OECD) , Paris, France.

Marion Bennie (M)

Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde , Glasgow, UK.

Marja-Liisa Dahl (ML)

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden.

Birgit Eiermann (B)

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden.

Werner Hackl (W)

Institute of Medical Informatics, UMIT-Private University for Health Sciences, Medical Informatics and Technology , Hall in Tirol, Austria.

Tora Hammar (T)

E-health Institute, Department of Medicine and Optometry, Linnaeus University , Kalmar, Sweden.

Paul Hjemdahl (P)

Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet , Stockholm, Sweden.

Sabine Koch (S)

Health Informatics Centre, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet , Stockholm, Sweden.

Ilkka Kunnamo (I)

The Finnish Medical Society Duodecim , Helsinki, Finland.

Herve Le Louët (H)

Council for International Organizations of Medical Sciences (CIOMS) , Geneva, Switzerland.

Papapetrou Panagiotis (P)

Department of Computer and Systems Science, Stockholm University , Stockholm, Sweden.

Lembit Rägo (L)

Council for International Organizations of Medical Sciences (CIOMS) , Geneva, Switzerland.

Michael Spedding (M)

International Union of Basic and Clinical Pharmacology (IUPHAR) , Paris, France.

Hanna M Seidling (HM)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg University , Heidelberg, Germany.

Dina Demner-Fushman (D)

National Library of Medicine, National Institutes of Health, HHS , Bethesda, MD, USA.

Lars L Gustafsson (LL)

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital , Stockholm, Sweden.
Swedish Institute for Drug Informatics (SIDI) , Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH